Laurus Labs Limited — Important, 15-03-2025: General Updates

Laurus Labs has invested ₹833 crore in acquiring 83.3 million equity shares of KRKA Pharma Private Limited, a joint venture. This investment occurred through a rights issue at a face value of ₹10 per share, reflecting continued commitment to strategic growth in its joint venture interests. This significant investment enhances Laurus Labs’ stake in the venture, aligning with its broader growth strategy and potentially strengthening its market position in the pharmaceutical sector. Investors should watch closely as this development could lead to improved revenue contributions in the future.